CSS
EVH icon

Cubist Systematic Strategies’s Evolent Health EVH Stock Holding History

Cubist Systematic Strategies’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$3.56M Buy
+421,387
New +$4.09M 0.02% 1199
2025
Q1 		– Sell
-50,144
Closed -$507K – 3037
2024
Q4 		$564K Buy
+50,144
New +$881K ﹤0.01% 2128
2024
Q3 		– Sell
-101,258
Closed -$2.61M – 3130
2024
Q2 		$1.94M Sell
101,258
-214,460
-68% -$5.48M 0.01% 1357
2024
Q1 		$10.4M Buy
315,718
+313,949
+17,747% +$10M 0.06% 515
2023
Q4 		$58.4K Buy
1,769
+49
+3% +$1.39K ﹤0.01% 3257
2023
Q3 		$46.8K Buy
+1,720
New +$47.8K ﹤0.01% 3037
2023
Q2 		– Sell
-15,341
Closed -$498K – 3740
2023
Q1 		$498K Sell
15,341
-9,359
-38% -$296K ﹤0.01% 2660
2022
Q4 		$694K Sell
24,700
-97,827
-80% -$2.8M ﹤0.01% 2770
2022
Q3 		$4.4M Buy
122,527
+72,584
+145% +$2.56M 0.02% 1202
2022
Q2 		$1.53M Sell
49,943
-59,544
-54% -$1.74M 0.01% 2099
2022
Q1 		$3.54M Buy
109,487
+73,199
+202% +$1.92M 0.03% 1012
2021
Q4 		$1M Buy
36,288
+34,095
+1,555% +$978K 0.01% 1915
2021
Q3 		$68K Sell
2,193
-21,468
-91% -$515K ﹤0.01% 2798
2021
Q2 		$500K Buy
23,661
+7,400
+46% +$148K 0.01% 2007
2021
Q1 		$328K Sell
16,261
-10,256
-39% -$195K ﹤0.01% 2201
2020
Q4 		$425K Sell
26,517
-105,027
-80% -$1.39M 0.01% 1863
2020
Q3 		$1.63M Sell
131,544
-1,356
-1% -$15.9K 0.02% 1031
2020
Q2 		$946K Buy
132,900
+38,902
+41% +$261K 0.02% 1221
2020
Q1 		$510K Buy
93,998
+82,898
+747% +$740K 0.01% 1249
2019
Q4 		$100K Buy
11,100
+4,300
+63% +$34.9K ﹤0.01% 2188
2019
Q3 		$49K Sell
6,800
-74,824
-92% -$537K ﹤0.01% 2042
2019
Q2 		$649K Sell
81,624
-54,220
-40% -$642K 0.01% 1311
2019
Q1 		$1.71M Buy
+135,844
New +$2.15M 0.06% 507
2018
Q4 		– Sell
-8,575
Closed -$244K – 2121
2018
Q3 		$244K Buy
+8,575
New +$205K 0.01% 1288
2018
Q2 		– Sell
-400
Closed -$6K – 1857
2018
Q1 		$6K Sell
400
-2,200
-85% -$31.5K ﹤0.01% 1782
2017
Q4 		$32K Sell
2,600
-20,864
-89% -$294K ﹤0.01% 1812
2017
Q3 		$418K Sell
23,464
-59,410
-72% -$1.22M 0.02% 935
2017
Q2 		$2.1M Buy
82,874
+68,880
+492% +$1.66M 0.13% 178
2017
Q1 		$312K Buy
+13,994
New +$269K 0.02% 880
2016
Q4 		– Sell
-3,816
Closed -$94K – 1759
2016
Q3 		$94K Buy
+3,816
New +$89.2K 0.01% 1485

Other funds holding EVH

CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cubist Systematic Strategies's EVH Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Evolent Health (EVH) in Q3 2025: 421,387 shares worth $3.56M. The stake represents 0.02% of the portfolio and ranks #1199 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in EVH as recently as Q4 2024.

Cubist Systematic Strategies first reported a position in EVH in Q3 2016 and has held it in 30 quarters since. The position peaked at $10.4M in Q1 2024. 240 funds tracked by Wall St. Rank hold EVH as of Q3 2025.

  • Cubist Systematic Strategies held 421,387 shares of Evolent Health worth $3.56M as of Q3 2025.
  • Evolent Health was a new Cubist Systematic Strategies position in Q3 2025.
  • Evolent Health made up 0.02% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1199 holding.
  • Cubist Systematic Strategies first reported a position in Evolent Health in Q3 2016 and has held it in 30 quarters since.
  • Cubist Systematic Strategies's Evolent Health position peaked at $10.4M in Q1 2024.
  • 240 funds tracked by Wall St. Rank held Evolent Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.